TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
IDL Biotech AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
42,990
|
36,797
|
22,897 |
| Financial expenses |
14
|
6
|
2 |
| Earnings before taxes |
-4,799
|
250
|
-12,737 |
| EBITDA |
-3,708
|
3,286
|
-12,307 |
| Total assets |
33,747
|
40,241
|
41,314 |
| Current assets |
26,414
|
33,084
|
35,185 |
| Current liabilities |
8,076
|
9,772
|
6,096 |
| Equity capital |
25,578
|
30,377
|
35,127 |
| - share capital |
25,225
|
25,224
|
25,224 |
| Employees (average) |
23
|
20
|
16 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
75.8%
|
75.5%
|
85.0% |
| Turnover per employee |
1,869
|
1,840
|
1,431 |
| Profit as a percentage of turnover |
-11.2%
|
0.7%
|
-55.6% |
| Return on assets (ROA) |
-14.2%
|
0.6%
|
-30.8% |
| Current ratio |
327.1%
|
338.6%
|
577.2% |
| Return on equity (ROE) |
-18.8%
|
0.8%
|
-36.3% |
| Change turnover |
6,193
|
13,900
|
1,149 |
| Change turnover % |
17%
|
61% | |
| Chg. No. of employees |
3
|
4
|
-2 |
| Chg. No. of employees % |
15%
|
25% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.